Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project

NCT03297346 is registered in ClinicalTrials.gov with French Nuclear Safety and Radiation Protection Authority (ASNR) as lead sponsor.

NCT NCT03297346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project
Lead sponsor
French Nuclear Safety and Radiation Protection Authority (ASNR)
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
May 31, 2021
Enrollment
250 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female